Literature DB >> 10398536

Retinoic acid biosynthetic enzyme ALDH1 localizes in a subset of retinoid-dependent tissues during xenopus development.

H L Ang1, G Duester.   

Abstract

Control of retinoic acid synthesis in vertebrate organisms is undoubtedly important for regulating the numerous retinoid signaling events which occur during development. The mechanisms which accomplish this task involve enzymes such as class I aldehyde dehydrogenase (ALDH1), which has recently been found to be conserved from amphibians to mammals and which functions as a retinoic acid biosynthetic enzyme in vivo. Here we have found that Xenopus ALDH1 mRNA and protein is expressed in a subset of retinoid-dependent tissues which develop shortly after neurulation during the tail bud stages. ALDH1 mRNA was first clearly detectable by in situ hybridization in stage 28 tail bud embryos localized in the olfactory placode and pronephros, and at stage 35 mRNA was also detected in the pronephric duct. Antibodies were generated against Xenopus ALDH1, and immunohistochemistry was used to demonstrate that ALDH1 protein accumulates in the olfactory placode, pronephros, and dorsal retina at stage 28, and additionally in the lens placode and pronephric duct at stage 35. Neither ALDH1 mRNA nor protein was detected in the posterior region of Xenopus embryos during the tail bud stages. In contrast to neurula stage embryos in which retinoic acid is distributed in an anteroposterior gradient with the high end posteriorly, we found that tail bud stage embryos have retinoic acid present in significant levels in both the head and trunk regions, but with no detection in the posterior region. These findings are consistent with ALDH1 contributing to retinoic acid synthesis needed for development of certain head structures (olfactory placodes, dorsal retina, lens placode) and certain trunk structures (pronephros and pronephric duct). Dev Dyn 1999;215:264-272. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10398536     DOI: 10.1002/(SICI)1097-0177(199907)215:3<264::AID-AJA8>3.0.CO;2-I

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  6 in total

1.  Retinoic acid modulates retinaldehyde dehydrogenase 1 gene expression through the induction of GADD153-C/EBPbeta interaction.

Authors:  Guillermo Elizondo; Irma M Medina-Díaz; Raymundo Cruz; Frank J Gonzalez; Libia Vega
Journal:  Biochem Pharmacol       Date:  2008-10-17       Impact factor: 5.858

2.  Ethanol induces embryonic malformations by competing for retinaldehyde dehydrogenase activity during vertebrate gastrulation.

Authors:  Hadas Kot-Leibovich; Abraham Fainsod
Journal:  Dis Model Mech       Date:  2009-04-06       Impact factor: 5.758

3.  Targeted disruption of Aldh1a1 (Raldh1) provides evidence for a complex mechanism of retinoic acid synthesis in the developing retina.

Authors:  Xiaohong Fan; Andrei Molotkov; Shin-Ichi Manabe; Christine M Donmoyer; Louise Deltour; Mario H Foglio; Arnold E Cuenca; William S Blaner; Stuart A Lipton; Gregg Duester
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

4.  Retinoic acid synthesis and functions in early embryonic development.

Authors:  Richard Kin Ting Kam; Yi Deng; Yonglong Chen; Hui Zhao
Journal:  Cell Biosci       Date:  2012-03-22       Impact factor: 7.133

5.  4-(N,N-dipropylamino)benzaldehyde inhibits the oxidation of all-trans retinal to all-trans retinoic acid by ALDH1A1, but not the differentiation of HL-60 promyelocytic leukemia cells exposed to all-trans retinal.

Authors:  James Russo; Annette Barnes; Katie Berger; Jay Desgrosellier; Jennifer Henderson; Ana Kanters; Lubo Merkov
Journal:  BMC Pharmacol       Date:  2002-02-12

6.  Retinoic Acid Signaling Regulates Differential Expression of the Tandemly-Duplicated Long Wavelength-Sensitive Cone Opsin Genes in Zebrafish.

Authors:  Diana M Mitchell; Craig B Stevens; Ruth A Frey; Samuel S Hunter; Ryuichi Ashino; Shoji Kawamura; Deborah L Stenkamp
Journal:  PLoS Genet       Date:  2015-08-21       Impact factor: 5.917

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.